Prolonging survival by reducing arrhythmic death: Pharmacologic therapy of ventricular tachycardia and fibrillation

American Journal of Cardiology

Volumn 80, Issue 8 A, 1997, Pages

  Reiffel, James A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; DEFIBRILLATOR; DEVICE; ELECTROCARDIOGRAPHY MONITORING; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART DEATH; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; SURVIVAL; SYMPATHETIC TONE;

EID: 0030807858     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00713-3     Document Type: Article

References (19)

1. Mason JW. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med. 329:1993;445-451.
2. Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, von Leitner E-R. A comparison of electrophysiologically guided antiarrhythmic drug therapy with β-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 327:1992;987-992.
3. Steinbeck G, Greene HL. Management of patients with life-threatening sustained ventricular tachyarrhythmias - the role of guided antiarrhythmic drug therapy. Prog Cardiovasc Dis. 38:1996;419-428.
4. Siebels J, Cappato R, Ruppel R, Schneider MAE, Kuck K-H. ICD versus drugs in cardiac arrest survivors preliminary results of the Cardiac Arrest Study Hamburg . PACE. 16:1993;552-558.
5. Siebels J, Kuck K-H. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 127:1994;1139-1144.
6. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med. 329:1993;452-458.
7. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol. 72:1993;280-287.
8. Reiffel JA, Reiter MJ, Freedman RA, Mann D, Huang SKS, Hahn E, Hartz V, Mason J. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial. Prog Cardiovasc Dis. 38:1996;359-370.
9. Mason JW, Marcus FI, Bigger JT, Lazzara R, Reiffel JA, Reiter MJ, Mann D. A summary and assessment of the findings and conclusions of the ESVEM trial. Prog Cardiovasc Dis. 38:1996;347-358.
10. Kehoe RF, MacNeil DJ, Zheutlin TA, Ezri MD, Nazari J, Spangenberg RB, Dunnington C, Lueken M. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents. Am J Cardiol. 72:(suppl):1993;56A-66A.
11. Cavusoglu E, Frishman WH. Sotalol a new β-adrenergic blocker for ventricular arrhythmias . Prog Cardiovasc Dis. 37:1995;423-440.
12. Reiffel JA, Hahn E, Hartz V, Reiter MJ. Sotalol for ventricular tachyarrhythmias β blocking and class III contributions; and relative efficacy versus class I drugs after prior drug failure . Am J Cardiol. 80:(suppl):1997;45G-55G.
13. Hallstrom AP, Cobb LA, Yu BH, Weaver WD, Fahrenbruch CE. An antiarrhythmic drug experience in 941 patients resuscitated from initial cardiac arrest between 1970 and 1985. Am J Cardiol. 68:1991;1025-1031.
14. Roberts SA, Viana MA, Nazari J, Bauman JL. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone a compilation of clinical observations using meta-analysis . PACE. 17:1994;1590-1602.
15. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Eur Heart J. 10:1989;685-694.
16. Kavoor P, Yung A, Byth K, Eipper VE, Cousins KL, Uther JB, Cooper MJ, Ross DL. Comparison of sotalol, amiodarone, and automatic implantable cardioverter defibrillator for treatment of documented spontaneous sustained ventricular tachyarrhythmias secondary to coronary artery disease (Abstr.) . Circulation. 92:1995;I-782.
17. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction EMIAT . Lancet. 349:1997;667-674.
18. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations CAMIAT . Lancet. 349:1997;675-682.
19. Antiarrhythmics versus implantable defibrillators (AVID) - rationality, design, and methods. Am J Cardiol. 75:1995;470-475.